Validation of the alcohol, smoking and substance involvement screening test (ASSIST) R Humeniuk, R Ali, TF Babor, M Farrell, ML Formigoni, J Jittiwutikarn, ... Addiction 103 (6), 1039-1047, 2008 | 1170 | 2008 |
Global statistics on alcohol, tobacco and illicit drug use: 2017 status report A Peacock, J Leung, S Larney, S Colledge, M Hickman, J Rehm, ... Addiction 113 (10), 1905-1926, 2018 | 1048 | 2018 |
Substitution treatment of injecting opioid users for prevention of HIV infection L Gowing, M Farrell, R Bornemann, LE Sullivan, R Ali Cochrane database of systematic reviews, 2008 | 683 | 2008 |
Global statistics on addictive behaviours: 2014 status report LR Gowing, RL Ali, S Allsop, J Marsden, EE Turf, R West, J Witton Addiction 110 (6), 904-919, 2015 | 540 | 2015 |
Alpha2‐adrenergic agonists for the management of opioid withdrawal L Gowing, M Farrell, R Ali, JM White Cochrane Database of Systematic Reviews, 2016 | 505 | 2016 |
The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): manual for use in primary care R Humeniuk, S Henry-Edwards, R Ali, V Poznyak, MG Monteiro, ... World Health Organization, 2010 | 466 | 2010 |
Buprenorphine for the management of opioid withdrawal L Gowing, R Ali, JM White Cochrane Database of Systematic Reviews, 2009 | 437 | 2009 |
Methadone at tapered doses for the management of opioid withdrawal L Amato, M Davoli, MMF Ferri, R Ali Cochrane Database of Systematic Reviews, 2003 | 395 | 2003 |
Buprenorphine versus methadone maintenance therapy: a randomized double‐blind trial with 405 opioid‐dependent patients RP Mattick, R Ali, JM White, S O'Brien, S Wolk, C Danz Addiction 98 (4), 441-452, 2003 | 370 | 2003 |
Hyperalgesic responses in methadone maintenance patients M Doverty, JM White, AA Somogyi, F Bochner, R Ali, W Ling Pain 90 (1-2), 91-96, 2001 | 364 | 2001 |
Validation of the world health organization alcohol, smoking and substance involvement screening test (ASSIST): report of results from the Australian site DAL Newcombe, RE Humeniuk, R Ali Drug and alcohol review 24 (3), 217-226, 2005 | 315 | 2005 |
The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS) J Ross, M Teesson, S Darke, M Lynskey, R Ali, A Ritter, R Cooke Drug and alcohol review 24 (5), 411-418, 2005 | 301 | 2005 |
Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDS P Lawrinson, R Ali, A Buavirat, S Chiamwongpaet, S Dvoryak, B Habrat, ... Addiction 103 (9), 1484-1492, 2008 | 299 | 2008 |
Experience of non‐fatal overdose among heroin users in Adelaide, Australia: circumstances and risk perceptions C Mcgregor, S Darke, R Ali, P Christie Addiction 93 (5), 701-711, 1998 | 277 | 1998 |
Exposure to opioid maintenance treatment reduces long‐term mortality A Gibson, L Degenhardt, RP Mattick, R Ali, J White, S O'Brien Addiction 103 (3), 462-468, 2008 | 257 | 2008 |
Dose-related psychotic symptoms in chronic methamphetamine users: evidence from a prospective longitudinal study R McKetin, DI Lubman, AL Baker, S Dawe, RL Ali JAMA psychiatry 70 (3), 319-324, 2013 | 248 | 2013 |
A randomized controlled trial of a brief intervention for illicit drugs linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in clients recruited … R Humeniuk, R Ali, T Babor, MLO Souza‐Formigoni, RB de Lacerda, ... Addiction 107 (5), 957-966, 2012 | 243 | 2012 |
Responding to global stimulant use: challenges and opportunities M Farrell, NK Martin, E Stockings, A Bórquez, JA Cepeda, L Degenhardt, ... The Lancet 394 (10209), 1652-1667, 2019 | 239 | 2019 |
A review of biological indicators of illicit drug use, practical considerations and clinical usefulness K Wolff, M Farrell, J Marsden, MG Monteiro, R Ali, S Welch, J Strang Addiction 94 (9), 1279-1298, 1999 | 235 | 1999 |
The health effects of ecstasy: a literature review LR Gowing, SM HENRY‐EDWARDS, RJ Irvine, RL Ali Drug and alcohol review 21 (1), 53-63, 2002 | 223 | 2002 |